Both in Pharmaceuticals
Telomir Pharmaceuticals vs Rani Therapeutics Holdings
Over the past year TELO returned −37.7% and RANI returned −59.3%; their daily moves had a correlation of 0.19.
TELO −37.7% RANI −59.3%Growth of $1, one year, split-adjusted
| Metric | TELO | RANI |
|---|---|---|
| Price | $0.9352 | $0.5900 |
| Market cap | $68.9M | $68.1M |
| Today | −3.01% | −2.54% |
| 1 month | −20.1% | −25.8% |
| 6 months | −33.2% | −37.2% |
| Year to date | −29.7% | −56.3% |
| 1 year | −37.7% | −64.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −432.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 14.0× |
| Net cash | $5.0M | $53.4M |
| Dividend yield | — | — |
| Volatility (60d) | 46.4% | 62.1% |
| Short % of float | 2.1% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).